Meta-Analysis of Cilostazol Versus Aspirin for the Secondary Prevention of Stroke
In conclusion, compared with aspirin, cilostazol is associated with significantly less hemorrhagic stroke, the combined end point of stroke, myocardial infarction, and vascular death, and total hemorrhagic events, with numerically fewer gastrointestinal bleeds when used for the secondary prevention of stroke.
Source: The American Journal of Cardiology - Category: Cardiology Authors: James J. DiNicolantonio, Carl J. Lavie, Hassan Fares, Arthur R. Menezes, James H. O'Keefe, Sripal Bangalore, Franz H. Messerli Tags: Miscellaneous Source Type: research
More News: Aspirin | Cardiology | Cilostazol | Gastroenterology | Heart | Heart Attack | Hemorrhagic Stroke | Men | Stroke